A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus
Clinical trial NCT04060888 · WITHDRAWN
Trial details
- NCT number
- NCT04060888
- Sponsor
- Janssen Research & Development, LLC
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2022-01-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.